Structural simulation of adenosine phosphate via plumbagin and zoledronic acid competitively targets JNK/Erk to synergistically attenuate osteoclastogenesis in a breast cancer model
- Type
- Retraction
- Notice date
- 5/8/2019 0:00
- Journal
- Cell Death & Disease
- Publisher
- Springer - Nature Publishing Group
- Notice DOI
- 10.1038/s41419-019-1606-1
- Original paper DOI
- 10.1038/cddis.2016.11